Spectral WaveFront for Vision Support

Additional Details from the Manufacturer

This item information is coming from the manufacturer. Some of the details may vary from the Nellis Auction listing. Please check the Quality Rating and Notes for information specific to this listing

More features

• The WaveFront is meticulously engineered and tested to deliver specific 670nm and 810nm light spectrum at precise energy levels (~5 mw/cm2). These wavelengths have been extensively peer-reviewed in studies for age related macular degeneration (AMD), dry eye & meibomian gland dysfunction, chalazia (eyelid cyst) management and retinal vein occlusion macular oedema (RVO). See our Evidence Alignment Paper at kyperspectral.com to review the WaveFront's alignment with peer-reviewed studies in the field of low level laser therapy / PBM for its safe and effective use for ocular conditions.